Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis
Open Access
- 31 January 2024
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 30 (4) , 435-447
Abstract
The histone lysine demethylase KDM5B is frequently up-regulated in various human cancer cells. However, its expression and functional role in human acute myeloid leukemia (AML) cells remain unclear. Here, we found that the expression level of KDM5B is high in primary human AML cells. We have demonstrated that knocking down KDM5B leads to apoptosis and impairs proliferation in primary human AML and some human AML cell lines. We further identified miR-140-3p as a downstream target gene of KDM5B. KDM5B expression was inversely correlated with the miR-140-3p level in primary human AML cells. Molecular studies showed that silencing KDM5B enhanced H3K4 trimethylation (H3K4me3) at the promoter of miR-140-3p, leading to high expression of miR-140-3p, which in turn inhibited B-cell CLL/lymphoma 2 (BCL2) expression. Finally, we demonstrate that the defective proliferation induced by KDM5B knockdown (KD) can be rescued with the miR-140-3p inhibitor or enhanced by combining KDM5B KD with a BCL2 inhibitor. Altogether, our data support the conclusion that KDM5B promotes tumorigenesis in human AML cells through the miR-140-3p/BCL2 axis. Targeting the KDM5B/miR-140-3p/BCL2 pathway may hold therapeutic promise for treating human AML.Keywords
This publication has 47 references indexed in Scilit:
- Cellular Senescence: Defining a Path ForwardCell, 2019
- KDM5 demethylases and their role in cancer cell chemoresistanceInternational Journal of Cancer, 2018
- DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancersCancer Letters, 2016
- MicroRNA as Biomarkers and DiagnosticsJournal of Cellular Physiology, 2015
- Akute Leukämien des ErwachsenenDer Pathologe, 2015
- The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic PotentialCancer Cell, 2015
- Reasons for optimism in the therapy of acute leukemiaBest Practice & Research Clinical Haematology, 2015
- Role for Dpy-30 in ES Cell-Fate Specification by Regulation of H3K4 Methylation within Bivalent DomainsCell, 2011
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem CellsCell, 2006